EYPT

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) is a specialized pharmaceutical company founded in 1987 and headquartered in Watertown, Massachusetts. Originally incorporated as pSivida Corp, the company rebranded to EyePoint Pharmaceuticals in March 2018 to better reflect its focus on ophthalmic treatments. The company has evolved from a diversified pharmaceutical entity into a clinical-stage biopharmaceutical company dedicated exclusively to developing and commercializing innovative treatments for serious eye diseases. EyePoint operates through strategic partnerships across the United States, China, and the United Kingdom, leveraging its proprietary sustained-release drug delivery technology to address unmet medical needs in ophthalmology.